Back to Search
Start Over
Adrenergic stimulation-released 5-HT stored in adrenergic nerves inhibits CGRPergic nerve-mediated vasodilatation in rat mesenteric resistance arteries.
- Source :
-
British journal of pharmacology [Br J Pharmacol] 2012 Aug; Vol. 166 (7), pp. 2084-94. - Publication Year :
- 2012
-
Abstract
- Background and Purpose: 5-HT is taken up by and stored in adrenergic nerves and periarterial nerve stimulation (PNS) releases 5-HT to cause vasoconstriction in rat mesenteric arteries. The present study investigated whether PNS-released 5-HT stored in adrenergic nerves affects the function of perivascular calcitonin gene-related peptide-containing (CGRPergic) nerves.<br />Experimental Approach: Rat mesenteric vascular beds without endothelium and with active tone were perfused with Krebs solution. Changes in perfusion pressure in response to PNS and CGRP injection were measured before (control) and after perfusion of Krebs solution containing 5-HT (10 µM) for 20 min. Distributions of 5-HT- and TH-immunopositive fibres in mesenteric arteries were studied using immunohistochemical methods.<br />Key Results: PNS (1-4 Hz) frequency dependently caused adrenergic nerve-mediated vasoconstriction followed by CGRPergic nerve-mediated vasodilatation. 5-HT treatment inhibited PNS-induced vasodilatation without affecting exogenous CGRP-induced vasodilatation, while it augmented PNS-induced vasoconstriction. Guanethidine (adrenergic neuron blocker), methysergide (non-selective 5-HT receptor antagonist) and BRL15572 (selective 5-HT1D receptor antagonist) abolished inhibition of PNS-induced vasodilatation in 5-HT-treated preparations. Combined treatment with 5-HT and desipramine (catecholamine transporter inhibitor), but not fluoxetine (selective 5-HT reuptake inhibitor), did not inhibit PNS-induced vasodilatation. Exogenous 5-HT inhibited PNS-induced vasodilatation, which was antagonized by methysergide. In immunohistochemical experiments, 5-HT-immunopositive nerves, colocalized with adrenergic TH-immunopositive nerves, were observed only in 5-HT-treated mesenteric arteries, but not in control preparations or arteries co-treated with desipramine.<br />Conclusions and Implications: These results suggest that 5-HT can be taken up by and released from adrenergic nerves in vitro by PNS to inhibit CGRPergic nerve transmission in rat mesenteric arteries.<br /> (© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.)
- Subjects :
- Adrenergic Agents pharmacology
Adrenergic Uptake Inhibitors pharmacology
Animals
Desipramine pharmacology
Fluoxetine pharmacology
Guanethidine pharmacology
In Vitro Techniques
Male
Mesenteric Arteries drug effects
Mesenteric Arteries innervation
Methoxamine pharmacology
Rats
Rats, Wistar
Serotonin Antagonists pharmacology
Selective Serotonin Reuptake Inhibitors pharmacology
Vasoconstriction drug effects
Vasodilation drug effects
Adrenergic Neurons physiology
Calcitonin Gene-Related Peptide physiology
Mesenteric Arteries physiology
Serotonin physiology
Subjects
Details
- Language :
- English
- ISSN :
- 1476-5381
- Volume :
- 166
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- British journal of pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 22394392
- Full Text :
- https://doi.org/10.1111/j.1476-5381.2012.01935.x